Coronavirus : Hydroxychloroquine clinical trials will resume, says WHO – TV9

Watch LIVE: https://goo.gl/w3aQde

Today’s Top News: https://goo.gl/5YuScD

Visit Website: https://www.tv9telugu.com/

►TV9 LIVE : https://bit.ly/2FJGPps
►Subscribe to Tv9 Telugu Live: https://goo.gl/lAjMru
►Subscribe to Tv9 Entertainment Live: https://bit.ly/2Rg6nzL
►Big News Big Debate : https://bit.ly/2sjc9Iu
►Encounter With Murali Krishna : https://bit.ly/380Nvf5
► Download Tv9 Android App: http://goo.gl/T1ZHNJ
► Download Tv9 IOS App: https://goo.gl/abC1bS read more

The World Health Organisation has dropped the malarial drug hydroxychloroquine from its coronavirus drug treatment trial.

The drug has been praised by President Trump who has admitted taking it himself.

For more on the safety concerns which led to the WHO’s decision, click here: https://www.telegraph.co.uk/news/2020/05/26/world-health-organisation-suspends-trial-hydroxychloroquine/

Get the latest headlines: https://www.telegraph.co.uk/

Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK’s best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture. read more

Australia’s first human trials of a potential COVID-19 vaccine started in Melbourne today, with about 130 people involved in the program.

Clinical research organisation the Nucleus Network will be in charge of the early stages of testing the vaccine NVX-CoV2373, before the trial expands to Brisbane within a week.

The participants are healthy people between 18 and 59 years old.

Victoria’s Parliamentary Secretary for Medical Research, Frank McGuire, said the trial was a significant step forward in the race for a coronavirus vaccine. read more

CanSino Biologics, a Chinese company developing a COVID-19 vaccine with the help of some Canadian scientists, saw some early success in the first phase of clinical trials.

Welcome to The National, the flagship nightly newscast of CBC News.

»»» Subscribe to The National to watch more videos here: https://www.youtube.com/user/CBCTheNational?sub_confirmation=1

Voice your opinion and connect with us online:

Facebook | https://www.facebook.com/thenational
Twitter | https://twitter.com/CBCTheNational
Instagram | https://www.instagram.com/cbcthenational read more

The Business Secretary has outlined plans to develop a vaccine as coronavirus-related deaths have increased to 34,636 in the UK.

In the daily coronavirus briefing, Alok Sharma said if trials of Oxford’s vaccine are successful, AstraZeneca will work to make 30 million doses available to the UK by September.

He said another £93m will be put into the building of a vaccine centre – now scheduled to open in summer 2021 – which would be able to produce enough vaccines for the entire UK population within six months. read more

The first Canadian clinical trials for a possible COVID-19 vaccine have been approved by Health Canada. Dr. Scott Halperin, the director of the Canadian Center for Vaccinology, explains the different phases of testing that a potential vaccine would have to go through.

To read more: http://cbc.ca/1.5573283

»»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS

Connect with CBC News Online:

For breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX
Find CBC News on Facebook: http://bit.ly/1WjG36m
Follow CBC News on Twitter: http://bit.ly/1sA5P9H
For breaking news on Twitter: http://bit.ly/1WjDyks
Follow CBC News on Instagram: http://bit.ly/1Z0iE7O read more

Researchers at Pfizer say a new coronavirus vaccine trial now underway in the U.S. could lead to a vaccine for emergency use by as soon as September. The trial involves trying to alter the genetic code of the virus. NBC’s Tom Costello reports for TODAY from Washington, D.C.
» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. read more

A COVID-19 vaccine being developed in the United Kingdom may be available by September.
If successful, and with fast-tracked approval from the regulator, the first few million doses of the vaccine could be available by September.

Al Jazeera’s Jonah Hull reports.

– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/ read more

Trials for a new COVID-19 vaccine began on humans at Oxford University in the UK on Thursday.

Two volunteers took part part in the trials with one given the new vaccine and another given a ‘control’ which will not prevent the virus.

The global pandemic has sickened nearly 2,68 million people, killed more than 187,000 worldwide, crippled economies and forced restrictions on the movement of millions of people in an effort to stop the virus from spreading further and overwhelming health care systems. read more

Australia’s first human trials for a COVID-19 vaccine are set to begin. Subscribe: https://bit.ly/2noaGhv Get more breaking news at: https://bit.ly/2nobVgF

Join Nine News for the latest in news and events that affect you in your local city, as well as news from across Australia and the world.

Follow Nine News on Facebook: https://www.facebook.com/9News/
Follow Nine News on Twitter: https://twitter.com/9NewsAUS
Follow Nine News on Instagram: https://www.instagram.com/9news/

#9News #BreakingNews #NineNewsAustralia #9NewsAUS read more